TY - JOUR
T1 - Updated clinical practice recommendations for managing adults with 22q11.2 deletion syndrome
AU - Boot, Erik
AU - Óskarsdóttir, Sólveig
AU - Loo, Joanne C.Y.
AU - Crowley, Terrence Blaine
AU - Orchanian-Cheff, Ani
AU - Andrade, Danielle M.
AU - Arganbright, Jill M.
AU - Castelein, René M.
AU - Cserti-Gazdewich, Christine
AU - de Reuver, Steven
AU - Fiksinski, Ania M.
AU - Klingberg, Gunilla
AU - Lang, Anthony E.
AU - Mascarenhas, Maria R.
AU - Moss, Edward M.
AU - Nowakowska, Beata Anna
AU - Oechslin, Erwin
AU - Palmer, Lisa
AU - Repetto, Gabriela M.
AU - Reyes, Nikolai Gil D.
AU - Schneider, Maude
AU - Silversides, Candice
AU - Sullivan, Kathleen E.
AU - Swillen, Ann
AU - van Amelsvoort, Therese A.M.J.
AU - Van Batavia, Jason P.
AU - Vingerhoets, Claudia
AU - McDonald-McGinn, Donna M.
AU - Bassett, Anne S.
N1 - Funding Information:
The authors acknowledge the support and endorsement provided by The 22q11.2 Society (http://www.22qsociety.org) for this work, and inspiration from patients with 22q11.2DS, and their caregivers and clinicians. A.S.B. holds the Dalglish Chair in 22q11.2 Deletion Syndrome at the University Health Network and University of Toronto. No funding was received for this work. Conceptualization: E.B. A.S.B. D.M.M.-M. S.Ó.; Data Curation: E.B. D.M.A. J.M.A. R.M.C. T.B.C. C.C.-G. S.d.R. A.M.F. G.K. A.E.L. J.C.Y.L. M.R.M. E.M.M. B.A.N. E.O. A.O.-C. S.Ó. L.P. G.M.R. N.G.D.R. M.S. C.S. K.E.S. A.S. T.A.M.J.v.A. J.P.V.B. C.V. D.M.M.-M. A.S.B.; Formal Analysis: E.B. S.Ó. D.M.M.-M. A.S.B.; Investigation: E.B. S.Ó. D.M.M.-M. A.S.B.; Methodology: E.B. S.Ó. D.M.M.-M. A.S.B.; Project Administration: E.B. S.Ó. D.M.M.-M. A.S.B.; Resources: E.B. A.S.B. D.M.M.-M. S.Ó. J.C.Y.L. T.B.C. A.O.-C.; Supervision: E.B. S.Ó. D.M.M.-M. A.S.B.; Validation: E.B. A.S.B. D.M.M.-M. S.Ó.; Visualization: E.B. S.Ó. T.B.C. D.M.M.-M. A.S.B.; Writing-original draft: E.B. A.S.B. D.M.M.-M. S.Ó. D.M.A. J.M.A. R.M.C. C.C.-G. S.d.R. A.M.F. G.K. A.E.L. M.R.M. E.M.M. B.A.N. E.O. A.O.-C. L.P. G.M.R. N.G.D.R. M.S. C.S. K.E.S. A.S. T.A.M.J.v.A. J.P.V.B. C.V.; Writing-review and editing: E.B. A.S.B. D.M.M.-M. S.Ó. T.B.C. D.M.A. J.M.A. R.M.C. C.C.-G. S.d.R. A.M.F. G.K. A.E.L. J.C.Y.L. M.R.M. E.M.M. B.A.N. E.O. A.O.-C. L.P. G.M.R. N.G.D.R. M.S. C.S. K.E.S. A.S. T.A.M.J.v.A. J.P.V.B. C.V.
Publisher Copyright:
© 2023 The Authors
PY - 2023/3/1
Y1 - 2023/3/1
N2 - This review aimed to update the clinical practice guidelines for managing adults with 22q11.2 deletion syndrome (22q11.2DS). The 22q11.2 Society recruited expert clinicians worldwide to revise the original clinical practice guidelines for adults in a stepwise process according to best practices: (1) a systematic literature search (1992-2021), (2) study selection and synthesis by clinical experts from 8 countries, covering 24 subspecialties, and (3) formulation of consensus recommendations based on the literature and further shaped by patient advocate survey results. Of 2441 22q11.2DS-relevant publications initially identified, 2344 received full-text review, with 2318 meeting inclusion criteria (clinical care relevance to 22q11.2DS) including 894 with potential relevance to adults. The evidence base remains limited. Thus multidisciplinary recommendations represent statements of current best practice for this evolving field, informed by the available literature. These recommendations provide guidance for the recognition, evaluation, surveillance, and management of the many emerging and chronic 22q11.2DS-associated multisystem morbidities relevant to adults. The recommendations also address key genetic counseling and psychosocial considerations for the increasing numbers of adults with this complex condition.
AB - This review aimed to update the clinical practice guidelines for managing adults with 22q11.2 deletion syndrome (22q11.2DS). The 22q11.2 Society recruited expert clinicians worldwide to revise the original clinical practice guidelines for adults in a stepwise process according to best practices: (1) a systematic literature search (1992-2021), (2) study selection and synthesis by clinical experts from 8 countries, covering 24 subspecialties, and (3) formulation of consensus recommendations based on the literature and further shaped by patient advocate survey results. Of 2441 22q11.2DS-relevant publications initially identified, 2344 received full-text review, with 2318 meeting inclusion criteria (clinical care relevance to 22q11.2DS) including 894 with potential relevance to adults. The evidence base remains limited. Thus multidisciplinary recommendations represent statements of current best practice for this evolving field, informed by the available literature. These recommendations provide guidance for the recognition, evaluation, surveillance, and management of the many emerging and chronic 22q11.2DS-associated multisystem morbidities relevant to adults. The recommendations also address key genetic counseling and psychosocial considerations for the increasing numbers of adults with this complex condition.
KW - Adults
KW - Aging
KW - Clinical practice guidelines
KW - DiGeorge syndrome
KW - Treatment
U2 - 10.1016/j.gim.2022.11.012
DO - 10.1016/j.gim.2022.11.012
M3 - (Systematic) Review article
C2 - 36729052
SN - 1098-3600
VL - 25
JO - Genetics in Medicine
JF - Genetics in Medicine
IS - 3
M1 - 100344
ER -